Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Japan.
Department of Gastroenterology, Kansai Rosai Hospital, Amagasaki, Japan.
Dig Endosc. 2018 Mar;30(2):228-235. doi: 10.1111/den.12980. Epub 2017 Dec 7.
Differentiation between gastric adenocarcinoma and low-grade adenoma/dysplasia (LGA) on endoscopic forceps biopsy is difficult. We aim to clarify the incidence of carcinoma in specimens, obtained by endoscopic resection (ER), from cases that had been diagnosed as LGA (Vienna category 3) on endoscopic biopsy.
In this multicenter, prospective, observational study, patients with gastric adenoma (Vienna category 3 or 4.1) diagnosed on endoscopic forceps biopsy were enrolled. All the specimens were subjected to histopathological central review. Primary endpoint was the incidence of carcinoma (Vienna category 4.2 or over) among the biopsy-proven gastric LGA. Secondary endpoints were the histological findings of resected specimens, clinicopathological features of carcinoma, and short-term outcomes of all ER cases.
Ninety-five patients with 104 lesions diagnosed as gastric adenoma were enrolled. After central review of the biopsy specimens, 47 lesions were diagnosed as LGA and seven lesions (15%) as adenocarcinoma (95% confidence interval, 7.6-28%). Carcinoma was detected in lesions that had a minimum size of 6 mm; the incidence of carcinoma was higher in the larger lesions. There was a histological discrepancy between biopsy and ER material in more than 60% of the cases.
A substantial proportion of biopsy-proven gastric LGA specimens were diagnosed as adenocarcinoma after ER. This indicated histological discrepancy between biopsy-proven gastric LGA and histology of the resected material.
在胃镜活检中,胃腺癌和低级别腺瘤/异型增生(LGA)的鉴别诊断较为困难。本研究旨在明确内镜下切除(ER)标本中,经内镜活检诊断为 LGA(维也纳分类 3 类)病例的癌发生率。
本多中心前瞻性观察性研究纳入了经胃镜活检诊断为胃腺瘤(维也纳分类 3 类或 4.1 类)的患者。所有标本均进行组织病理学中心复查。主要终点是活检证实的胃 LGA 中癌(维也纳分类 4.2 类或以上)的发生率。次要终点是切除标本的组织学发现、癌的临床病理特征以及所有 ER 病例的短期结果。
95 例 104 处病变患者被纳入研究。经中央审查活检标本后,47 处病变诊断为 LGA,7 处病变(15%)诊断为腺癌(95%置信区间,7.6%-28%)。癌仅在最小直径≥6mm 的病变中被检出;且较大病变的癌发生率更高。在超过 60%的病例中,活检和 ER 标本之间存在组织学差异。
经 ER 后,活检证实的胃 LGA 标本中有相当一部分被诊断为腺癌。这表明活检证实的胃 LGA 与切除标本的组织学之间存在差异。